Block
XYZ
76.07
-0.47
-0.61%
Block
US · XYZ
#494 by market cap
Listed 2015
76.07
-0.47
-0.61%
Live - 5344 symbols - heartbeat 137s ago
· 2026-10-08 06:46
Pre-market
74.68
-1.82%
After-hours
75.85
-0.29%
Overnight
75.37
-0.92%
- Market cap
- 45.70B
- P/E (TTM)i
- 135.84
- P/Bi
- 2.07
- EPSi
- 2.10
- Div yieldi
- 0.00%
- 52W posi
- 72%
Reader sentiment
Are you bullish or bearish on XYZ?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.95, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.30% YoY
Margins
- Gross margin
- 42.82%
- Operating margin
- 12.59%
- Net margin
- 5.40%
Key ratios & quality
- Enterprise valuei
- 42.45B
- Altman Z-Scorei
- 2.95
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.30B | 4.71B | 9.50B | 17.66B | 17.53B | 21.92B | 24.12B | 24.19B |
| Gross profit | 1.30B | 1.89B | 2.73B | 4.42B | 5.99B | 7.50B | 8.89B | 10.36B |
| Selling & admin expenses | 750.40M | 1.06B | 1.69B | 2.60B | 3.74B | 4.23B | 4.13B | 4.27B |
| Research & development | 497.48M | 674.17M | 885.68M | 1.38B | 2.14B | 2.72B | 2.91B | 2.91B |
| Operating profit | 51.46M | 153.52M | 158.86M | 420.23M | -27.28M | 381.82M | 1.69B | 3.05B |
| Pretax profit | -36.13M | 378.21M | 215.97M | 157.46M | -565.32M | -29.14M | 1.36B | 1.69B |
| Tax | 2.33M | 2.77M | 2.86M | -1.36M | -12.31M | -8.02M | -1.51B | 385.70M |
| Net profit | -38.45M | 375.45M | 213.11M | 158.83M | -553.01M | -21.12M | 2.87B | 1.30B |
| Basic EPS | 0 | 1 | 0 | 0 | -1 | 0 | 5 | 2 |
| Diluted EPS | -0.09 | 0.81 | 0.44 | 0.33 | -0.93 | 0.02 | 4.56 | 2.10 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 5.77B | 6.05B | 6.11B | 6.25B | 6.06B | 6.62B |
| Gross profit | 2.29B | 2.54B | 2.66B | 2.87B | 2.91B | 3.17B |
| Selling & admin expenses | 996.26M | 998.97M | 1.14B | 1.13B | 1.51B | 1.49B |
| Research & development | 760.70M | 725.29M | 711.24M | 710.67M | 1.04B | 608.66M |
| Operating profit | 498.99M | 778.38M | 772.90M | 995.38M | 328.14M | 1.03B |
| Pretax profit | 227.05M | 659.38M | 601.53M | 201.95M | -392.58M | 301.48M |
| Tax | 38.33M | 121.05M | 139.93M | 86.40M | -83.98M | 214.41M |
| Net profit | 188.72M | 538.33M | 461.60M | 115.56M | -308.60M | 87.07M |
| Basic EPS | 0 | 1 | 1 | 0 | -1 | 0 |
| Diluted EPS | 0.30 | 0.87 | 0.74 | 0.19 | -0.52 | 0.15 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.11B | 3.22B | 7.76B | 11.62B | 15.62B | 17.82B | 19.88B | 22.86B |
| Cash & ST investments | 1.46B | 2.22B | 5.89B | 8.14B | 8.81B | 9.42B | 12.75B | 11.96B |
| Inventory | 28.63M | 47.68M | 61.13M | 77.06M | 97.70M | 110.10M | 104.99M | 158.32M |
| Total assets | 3.28B | 4.55B | 9.87B | 15.03B | 31.36B | 33.03B | 36.78B | 39.55B |
| Total current liabilities | 1.02B | 1.69B | 4.13B | 6.54B | 8.43B | 8.88B | 8.55B | 10.38B |
| Short-term debt | -- | 27.28M | 516.84M | 562.02M | 988.45M | 806.76M | 1.24B | 2.10B |
| Long-term debt | 899.70M | 938.83M | 2.59B | 4.56B | 4.99B | 4.97B | 6.40B | 6.61B |
| Total liabilities | 2,160,522,000.00 | 2,836,208,000.00 | 7,187,981,000.00 | 11,712,771,000.00 | 14,112,985,000.00 | 14,338,472,000.00 | 15,542,633,000.00 | 17,380,005,000.00 |
| Total equity | 1.12B | 1.72B | 2.68B | 3.31B | 17.25B | 18.69B | 21.23B | 22.17B |
| Retained earnings | -885.77M | -510.33M | -297.22M | -27.97M | -568.71M | -528.43M | 2.37B | 3.67B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 19.71B | 19.71B | 22.07B | 22.86B | 23.77B | 23.14B |
| Cash & ST investments | 12.76B | 11.72B | 13.59B | 11.96B | 13.26B | 12.27B |
| Inventory | 108.84M | 138.14M | 166.63M | 158.32M | 174.32M | 198.86M |
| Total assets | 36.40B | 36.86B | 39.18B | 39.55B | 39.99B | 39.16B |
| Total current liabilities | 8.69B | 10.07B | 10.11B | 10.38B | 11.97B | 10.48B |
| Short-term debt | 52.02M | 1.74B | 1.78B | 2.10B | 1.91B | 633.47M |
| Long-term debt | 5.73B | 4.12B | 6.06B | 6.61B | 5.98B | 6.31B |
| Total liabilities | 14,960,493,000.00 | 14,735,499,000.00 | 16,709,615,000.00 | 17,380,005,000.00 | 18,305,053,000.00 | 17,145,350,000.00 |
| Total equity | 21.44B | 22.12B | 22.47B | 22.17B | 21.68B | 22.01B |
| Retained earnings | 2.56B | 3.10B | 3.56B | 3.67B | 3.37B | 3.45B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 295.08M | 327.63M | 173.11M | 847.83M | 175.90M | 100.96M | 1.71B | 2.58B |
| Depreciation & amortization | 60.96M | 75.60M | 84.21M | 134.76M | 340.52M | 408.56M | 376.13M | 369.53M |
| Free cash flow | 232.29M | 265.13M | -15.29M | 543.51M | 5.09M | -50.19M | 1.55B | 2.42B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | 0 | 0 | -156.81M | -1.17B | -2.33B |
| Ending cash balance | 632.85M | 1.54B | 4.79B | 6.98B | 8.44B | 9.01B | 13.23B | 12.48B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 133.34M | 374.32M | 1.45B | 621.00M | 965.60M | 1.02B |
| Depreciation & amortization | 88.95M | 92.40M | 92.12M | 96.07M | 95.98M | 95.05M |
| Free cash flow | 101.45M | 343.01M | 1.40B | 579.80M | 935.02M | 966.61M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -445.30M | -692.20M | -403.03M | -790.13M | -635.99M | -64.95M |
| Ending cash balance | 13.09B | 12.14B | 13.95B | 12.48B | 13.49B | 12.85B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -4.03 | 26.48 | 9.69 | 5.59 | -5.28 | 0.05 | 14.50 | 6.01 |
| ROA %i | -1.41 | 9.59 | 2.96 | 1.40 | -2.39 | 0.03 | 8.18 | 3.42 |
| ROIC %i | -2.32 | 15.06 | 6.01 | 2.55 | -3.12 | 0.04 | 10.74 | 4.33 |
| 5-year avg ROE %i | -- | -35.47 | -1.75 | 5.70 | 6.49 | 7.31 | 4.91 | 4.17 |
| EBIT margin %i | 1.56 | 3.26 | 2.87 | 1.08 | -3.02 | 1.74 | 6.99 | 12.59 |
| FCF / sales %i | 7.04 | 8.55 | 2.56 | 3.08 | 0.03 | -- | 6.44 | 10.02 |
| Current ratioi | 2.07 | 1.90 | 1.88 | 1.78 | 1.85 | 2.01 | 2.33 | 2.20 |
| Quick ratioi | 1.95 | 1.81 | 1.83 | 1.57 | 1.68 | 1.87 | 2.16 | 2.01 |
| Debt / assetsi | 31.96 | 23.62 | 35.40 | 36.71 | 20.19 | 18.38 | 21.53 | 22.67 |
| LT debt / equityi | 93.59 | 61.09 | 111.00 | 151.37 | 31.03 | 28.16 | 31.41 | 30.94 |
| Interest coveragei | -- | -- | 4.79 | 5.75 | -14.60 | -- | -- | -- |
| Revenue CAGR (3Y) %i | 37.56 | 40.25 | 62.48 | 74.95 | 54.94 | 32.14 | 10.95 | 11.33 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -64.21 | 159.24 | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | 32.76 | -73.23 | -- | 41.91 | 681.09 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 12.93 | 14.27 | 14.78 | 6.01 | 3.74 | 1.62 |
| ROA %i | 7.26 | 7.95 | 8.30 | 3.42 | 2.11 | 0.94 |
| ROIC %i | 10.08 | 10.77 | 10.82 | 4.33 | 2.81 | 1.24 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.33 | 8.60 | 9.63 | 12.59 | 10.06 | 12.49 |
| FCF / sales %i | 5.00 | 4.45 | 7.64 | 10.02 | 13.31 | 15.50 |
| Current ratioi | 2.27 | 1.96 | 2.18 | 2.20 | 1.99 | 2.21 |
| Quick ratioi | 2.10 | 1.81 | 2.03 | 2.01 | 1.76 | 1.96 |
| Debt / assetsi | 16.61 | 16.61 | 20.68 | 22.67 | 20.34 | 18.31 |
| LT debt / equityi | 27.91 | 19.77 | 28.06 | 30.94 | 28.64 | 29.65 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Cash App is the largest reported line at 60.76% of revenue, across 3 reported segments.
- Square follows at 37.83%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Cash App60.76%
Square37.83%
Corporate and Other1.41%
Quote time 2026-10-08 06:46:16 · For reference only, not investment advice and not tailored to your situation.